Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this crucial final discussion on the current scenario of cancer. The field of oncology is in the midst of a transformative era, driven by the profound importance of genomic testing and remarkable advancements in both diagnosis and treatment. In the past, cancer was often categorized by its anatomical location, leading to a "one-size-fits-all" approach. However, with the integration of cutting-edge technologies, we can now precisely identify the unique molecular and genetic drivers of each patient's tumor. This shift toward personalized medicine has enabled the development of highly effective targeted therapies and immunotherapies, which offer superior outcomes and fewer side effects compared to traditional cytotoxic chemotherapy.
The central pillar of this revolution is genomic testing, which provides a detailed blueprint of a tumor's genetic makeup. By identifying specific mutations, fusions, or other genomic alterations, clinicians can select treatments that directly target these abnormalities. This not only enhances therapeutic efficacy but also helps predict treatment resistance and informs clinical trial eligibility. Furthermore, advancements in diagnostic techniques, such as liquid biopsies and next-generation sequencing, are making it possible to detect cancer at earlier stages and monitor treatment response with unprecedented accuracy. This empowers healthcare providers to make more informed decisions, ensuring each patient receives the most appropriate and advanced care available.
Therefore, join Dr. Poonam Patil for this final discussion to gain a comprehensive understanding of how genomic testing is reshaping the current scenario of cancer care. Listen to the expert insights, grasp the shared knowledge on advancements in diagnosis and treatment, and continue to follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.
2.
'It's rare and it's scary.' Dark spot on your fingernail could mean cancer
3.
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer
4.
Experts say oncology, primary care coordination necessary for best cancer patient outcomes
5.
How a California Oncologist Making $850k Spends Money
1.
Tazemetostat: A Promising New Treatment for Cancer
2.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
3.
Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines
4.
Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment
5.
Unlocking the Potential of Lymphocytes: Exploring the Role of These Immune System Cells
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation